Clinical Trials Insight: 700028225

Trial Profile

Clinical Trials Insight: 700028225

Phase of Trial: Phase I

Latest Information Update: 11 Jun 2008

At a glance

  • Drugs MRX 4 (Primary)
  • Indications Allergic rhinitis
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Celsus Therapeutics
  • Most Recent Events

    • 11 Jun 2008 Status changed to completed, according to a Morria Biopharmaceuticals media release.
    • 16 Jan 2008 Interim safety results reported in a Morria Biopharmaceuticals media release.
    • 06 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top